AltaRex Reanalyzes OvaRex IIb Results, Reaches Significance Feb. 1, 2002 By Brady Huggett No Comments
AltaRex Reanalyzes OvaRex IIb Results, Reaches Significance Feb. 1, 2002 By Brady Huggett No Comments
Signature Continues Acquisitions, Buys PDL’s Small-Molecule Unit Jan. 31, 2002 By Brady Huggett No Comments Signature BioScience Inc. is moving toward drug discovery and fueling the trek with acquisitions. (BioWorld Today)Read More
Signature Continues Acquisitions, Buys PDL’s Small-Molecule Unit Jan. 31, 2002 By Brady Huggett No Comments Signature BioScience Inc. is moving toward drug discovery and fueling the trek with acquisitions. (BioWorld Today)Read More
Maxim Begins Ceplene Phase III With Liver Metastases Patients Jan. 18, 2002 By Brady Huggett No Comments
